0001209191-17-028260.txt : 20170426 0001209191-17-028260.hdr.sgml : 20170426 20170426183613 ACCESSION NUMBER: 0001209191-17-028260 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170424 FILED AS OF DATE: 20170426 DATE AS OF CHANGE: 20170426 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RXi Pharmaceuticals Corp CENTRAL INDEX KEY: 0001533040 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 257 SIMARANO DRIVE STREET 2: SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 BUSINESS PHONE: (508) 767-3861 MAIL ADDRESS: STREET 1: 257 SIMARANO DRIVE STREET 2: SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dispersyn Gerrit CENTRAL INDEX KEY: 0001704417 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36304 FILM NUMBER: 17785720 MAIL ADDRESS: STREET 1: 257 SIMARANO DRIVE, SUITE 101 CITY: MARLBOROUGH STATE: MA ZIP: 01752 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-04-24 0 0001533040 RXi Pharmaceuticals Corp RXII 0001704417 Dispersyn Gerrit C/O 257 SIMARANO DRIVE, SUITE 101 MARLBOROUGH MA 01752 0 1 0 0 Chief Development Officer Stock option (right to buy) 0.65 2017-04-24 4 A 0 95000 0.00 A 2027-04-24 Common stock 95000 95000 D The stock option vests in equal monthly installments over four years beginning on the first monthly anniversary of the grant date. Caitlin Kontulis, attorney-in-fact 2017-04-26